Larimar Therapeutics (LRMR) PT Lowered to $5 at Baird

June 30, 2026 6:54 AM EDT
Get Alerts LRMR Hot Sheet
Price: $4.36 +2.11%

Rating Summary:
    12 Buy, 1 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Baird analyst Joel Beatty lowered the price target on Larimar Therapeutics (NASDAQ: LRMR) to $5.00 (from $7.00) while maintaining a Outperform rating.

You May Also Be Interested In





Related Categories

Analyst PT Change